Work

Abstract 7182: EZH2 inhibition as a therapeutic strategy for castration resistant prostate cancer in combination with AR-antagonist enzalutamide

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-7182

Authors: Shikhar Sharma, Jelena Petrovic, Sara Linker, Whijae Roh, Joan Cao, Sean Uryu, Zhenxiong Wang, Yong Zhang, Colin A. Flaveny, Conglin Fan, Tao Xie, Kimberly H. Kim, Xiaoli Wang, Robert A. Rollins, Gail P. Risbridger, Renea A. Taylor, Mitchell G. Lawrence, Thomas A. Paul, Pei-Pei Kung

Institutions: Pfizer (United States), Monash University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409636845

Cites:

Cited by: 1

Related to: 10